-
1
-
-
0028124528
-
P53 and human cancers
-
Lane DP. p53 and human cancers. Br Med Bull 1994 50 582 99.
-
(1994)
Br Med Bull
, vol.50
, pp. 582-99
-
-
Lane, D.P.1
-
2
-
-
0030481746
-
The significance of p53 mutations in human cancers
-
Pellegata NS Ranzani GN. The significance of p53 mutations in human cancers. Eur J Histochem 1996 40 273 82.
-
(1996)
Eur J Histochem
, vol.40
, pp. 273-82
-
-
Pellegata, N.S.1
Ranzani, G.N.2
-
3
-
-
0028841050
-
The clinical significance of p53 aberrations in human tumours
-
Bosari S Viale G. The clinical significance of p53 aberrations in human tumours. Virchows Arch 1995 47 229 41.
-
(1995)
Virchows Arch
, vol.47
, pp. 229-41
-
-
Bosari, S.1
Viale, G.2
-
5
-
-
0031971228
-
Multisite phosphorylation and the integration of stress signals at p53
-
Meek DW. Multisite phosphorylation and the integration of stress signals at p53. Cell Signal 1998 10 159 66.
-
(1998)
Cell Signal
, vol.10
, pp. 159-66
-
-
Meek, D.W.1
-
6
-
-
0030797585
-
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
-
Gu W Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997 90 595 606.
-
(1997)
Cell
, vol.90
, pp. 595-606
-
-
Gu, W.1
Roeder, R.G.2
-
7
-
-
0032530486
-
DNA damage activates p53 through a phosphorylation-acetylation cascade
-
Sakaguchi K Herrera JE Saito S et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998 12 2831 41.
-
(1998)
Genes Dev
, vol.12
, pp. 2831-41
-
-
Sakaguchi, K.1
Herrera, J.E.2
Saito, S.3
-
8
-
-
33645994216
-
Acetylation of p53 inhibits its ubiquitination by Mdm2
-
07. 11
-
Li M Luo J Brooks CL Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 2002 27 50 07 11.
-
(2002)
J Biol Chem
, vol.27
, pp. 50
-
-
Li, M.1
Luo, J.2
Brooks, C.L.3
Gu, W.4
-
9
-
-
0034458966
-
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination
-
Nakamura S Rosh JA Mukhopadhyay T. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol 2000 20 9391 8.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 9391-8
-
-
Nakamura, S.1
Rosh, J.A.2
Mukhopadhyay, T.3
-
10
-
-
0030667702
-
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
-
Shieh SY Ikeda M Taya Y Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997 91 325 34.
-
(1997)
Cell
, vol.91
, pp. 325-34
-
-
Shieh, S.Y.1
Ikeda, M.2
Taya, Y.3
Prives, C.4
-
11
-
-
0033118933
-
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization
-
Shieh SY Taya Y Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J 1999 18 1815 23.
-
(1999)
EMBO J
, vol.18
, pp. 1815-23
-
-
Shieh, S.Y.1
Taya, Y.2
Prives, C.3
-
12
-
-
0029972806
-
P53: Puzzle and paradigm
-
Ko LJ Prives C. p53: puzzle and paradigm. Genes Dev 1996 10 1054 72.
-
(1996)
Genes Dev
, vol.10
, pp. 1054-72
-
-
Ko, L.J.1
Prives, C.2
-
13
-
-
0037061764
-
Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells
-
Nakamura S Rosh JA Mukhopadhyay T. Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells. Oncogene 2002 21 2605 10.
-
(2002)
Oncogene
, vol.21
, pp. 2605-10
-
-
Nakamura, S.1
Rosh, J.A.2
Mukhopadhyay, T.3
-
15
-
-
0036625964
-
The promise and obstacle of p53 as a cancer therapeutic agent
-
Willis AS Chen X. The promise and obstacle of p53 as a cancer therapeutic agent. Curr Mol Med 2002 2 329 45.
-
(2002)
Curr Mol Med
, vol.2
, pp. 329-45
-
-
Willis, A.S.1
Chen, X.2
-
16
-
-
0031719125
-
P53: Prospects for cancer gene therapy
-
Soddu S Sacchi A. p53: prospects for cancer gene therapy. Cytokines Cell Mol Ther 1998 4 177 85.
-
(1998)
Cytokines Cell Mol Ther
, vol.4
, pp. 177-85
-
-
Soddu, S.1
Sacchi, A.2
-
17
-
-
0032448439
-
New p53-based anti-cancer therapeutic strategies
-
Wiman KG. New p53-based anti-cancer therapeutic strategies. Med Oncol 1998 15 222 8.
-
(1998)
Med Oncol
, vol.15
, pp. 222-8
-
-
Wiman, K.G.1
-
19
-
-
0028037530
-
A simple and efficient method for purification of infectious recombinant adenovirus
-
Kanegae Y Makimura M Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994 47 157 66.
-
(1994)
Jpn J Med Sci Biol
, vol.47
, pp. 157-66
-
-
Kanegae, Y.1
Makimura, M.2
Saito, I.3
-
20
-
-
0034114594
-
Enhancement of adenovirus-mediated gene transfer into dermal fibroblasts in vitro and in vivo by polyethylene glycol 6000
-
Ohsawa T Nakamura T Mihara M Sato K. Enhancement of adenovirus-mediated gene transfer into dermal fibroblasts in vitro and in vivo by polyethylene glycol 6000. J Dermatol 2000 27 244 51.
-
(2000)
J Dermatol
, vol.27
, pp. 244-51
-
-
Ohsawa, T.1
Nakamura, T.2
Mihara, M.3
Sato, K.4
-
21
-
-
0023277545
-
Single-step method of RNA isolation by acid guanidinium thiocynate-phenolchloroform extraction
-
Chomzynski P Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenolchloroform extraction. Anal Biochem 1987 162 156 9.
-
(1987)
Anal Biochem
, vol.162
, pp. 156-9
-
-
Chomzynski, P.1
Sacchi, N.2
-
22
-
-
0343461542
-
Isolation and characterization of the Drosophila alchol dehydrogenase gene
-
Goldberg DA. Isolation and characterization of the Drosophila alchol dehydrogenase gene. Proc Natl Acad Sci 1980 77 5794 8.
-
(1980)
Proc Natl Acad Sci
, vol.77
, pp. 5794-8
-
-
Goldberg, D.A.1
-
23
-
-
0029068871
-
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
-
Nicholson DW Ali A Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995 376 37 43.
-
(1995)
Nature
, vol.376
, pp. 37-43
-
-
Nicholson, D.W.1
Ali, A.2
Thornberry, N.A.3
-
24
-
-
0027359827
-
WAF1, a potential mediator of p53 tumor suppression
-
El-Deiry WS Tokino T Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993 75 817 25.
-
(1993)
Cell
, vol.75
, pp. 817-25
-
-
El-Deiry, W.S.1
Tokino, T.2
Velculescu, V.E.3
-
25
-
-
0027496935
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
-
Harper JW Adami GR Wei N Keyomarsi K Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993 75 805 16.
-
(1993)
Cell
, vol.75
, pp. 805-16
-
-
Harper, J.W.1
Adami, G.R.2
Wei, N.3
Keyomarsi, K.4
Elledge, S.J.5
-
26
-
-
9244247669
-
Regulation of p53 activity through lysine methylation
-
Chuikov S Kurash JK Wilson JR et al. Regulation of p53 activity through lysine methylation. Nature 2004 18 353 60.
-
(2004)
Nature
, vol.18
, pp. 353-60
-
-
Chuikov, S.1
Kurash, J.K.2
Wilson, J.R.3
-
27
-
-
0028069906
-
Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus
-
Liu TJ Zhang WW Taylor DL Roth JA Goepfert H Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994 54 3662 7.
-
(1994)
Cancer Res
, vol.54
, pp. 3662-7
-
-
Liu, T.J.1
Zhang, W.W.2
Taylor, D.L.3
Roth, J.A.4
Goepfert, H.5
Clayman, G.L.6
-
28
-
-
0028963221
-
In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma
-
Clayman GL el-Naggar AK Roth JA et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995 55 1 6.
-
(1995)
Cancer Res
, vol.55
, pp. 1-6
-
-
Clayman, G.L.1
El-Naggar, A.K.2
Roth, J.A.3
-
29
-
-
0028851771
-
Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo
-
Cirielli C Riccioni T Yang C et al. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 1995 63 673 9.
-
(1995)
Int J Cancer
, vol.63
, pp. 673-9
-
-
Cirielli, C.1
Riccioni, T.2
Yang, C.3
-
31
-
-
0029027072
-
Adenovirus mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells
-
Yang C Cirielli C Capogrossi MC Passaniti A. Adenovirus mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 1995 55 4210 13.
-
(1995)
Cancer Res
, vol.55
, pp. 4210-13
-
-
Yang, C.1
Cirielli, C.2
Capogrossi, M.C.3
Passaniti, A.4
-
32
-
-
0029103231
-
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice
-
Lesoon-Wood LA Kim WH Kleinman HK Weintraub BD Mixson AJ. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 1995 6 395 405.
-
(1995)
Hum Gene Ther
, vol.6
, pp. 395-405
-
-
Lesoon-Wood, L.A.1
Kim, W.H.2
Kleinman, H.K.3
Weintraub, B.D.4
Mixson, A.J.5
-
33
-
-
0030100291
-
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
-
Harris MP Sutjipto S Wills KN et al. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther 1996 3 121 30.
-
(1996)
Cancer Gene Ther
, vol.3
, pp. 121-30
-
-
Harris, M.P.1
Sutjipto, S.2
Wills, K.N.3
-
34
-
-
0026642375
-
Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions
-
Takahashi T Carbone D Takahashi T et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 1992 52 2340 43.
-
(1992)
Cancer Res
, vol.52
, pp. 2340-43
-
-
Takahashi, T.1
Carbone, D.2
Takahashi, T.3
-
36
-
-
0037169358
-
Apoptosis: A link between cancer genetics and chemotherapy
-
Johnstone RW Ruefli AA Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002 108 153 64.
-
(2002)
Cell
, vol.108
, pp. 153-64
-
-
Johnstone, R.W.1
Ruefli, A.A.2
Lowe, S.W.3
-
37
-
-
0037349289
-
P53 has a direct apoptogenic role at the mitochondria
-
Mihara M Erster S Zaika A et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003 11 577 90.
-
(2003)
Mol Cell
, vol.11
, pp. 577-90
-
-
Mihara, M.1
Erster, S.2
Zaika, A.3
-
38
-
-
0027524636
-
The incidence of p53 mutations increases with progression of head and neck cancer
-
Boyle JO Hakim J Koch W van der Riet P et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993 53 4477 80.
-
(1993)
Cancer Res
, vol.53
, pp. 4477-80
-
-
Boyle, J.O.1
Hakim, J.2
Koch, W.3
Van Der Riet, P.4
|